EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases (NCT04554914) | Pierre Fabre Medicament | 2021-07-14 |
Track EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD) automatically
Every clearance here is in the API, with alerts when new ones post.